Publication | Closed Access

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseUnstable AnginaCoronary Artery DiseasePharmacotherapyTime CoursePlatelet AntagonistMedicineCardiologyPlatelet InhibitionAnesthesiologyMyocardial Infarction